Current evidence supporting "letrozole" for ovulation induction

Journal of Human Reproductive Sciences

Volumn 6, Issue 2, 2013, Pages 93-98

  Kar, Sujata ^a  

^a Kar Hospital Pvt Ltd   (India)

Author keywords

Aromatase inhibitor; congenital malformations; letrozole; ovulation induction

Indexed keywords

ANASTROZOLE; CLOMIFENE CITRATE; ESTROGEN RECEPTOR; FOLLITROPIN; FOLLITROPIN RECEPTOR; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; METFORMIN; SOMATOMEDIN;

ADENOMYOSIS; CANCER PATIENT; COMPARATIVE STUDY; CONGENITAL MALFORMATION; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; ENDOMETRIOSIS; ENDOMETRIUM SARCOMA; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; LUTEAL PHASE; MEDICAL ABORTION; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCTIVE PROCEDURE; REVIEW; UTERUS MYOMA;

EID: 84884246990     PISSN: 09741208     EISSN: 19984766     Source Type: Journal    
DOI: 10.4103/0974-1208.117166     Document Type: Review

References (45)

1. Mitwally MF, Casper RF. Aromatase Inhibition: A novel method of ovulation induction in women with polycystic ovarian syndrome. Reprod Technol 2000;10:244-7
2. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2000;75:305-9
3. Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril 2005;84 (Suppl 1):S95
4. Casper RF, Mitwally MF. A historical perspective of aromatase inhibitors for ovulation induction. Fertil Steril 2012;98:1352-5
5. Kamat A, Hinshelwood MM, Murry BA, Mendelson CR. Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrionol Metab 2002;133:122-8
6. Naftolin F, MacLusky NJ. Aromatization hypothesis revisisted. In: Serio M, editor. Differentiation; Basic and Clinical Aspects. New York: Raven Press; 1984. p. 79-91
7. Naftolin F, MacLusky NJ, Leranth CZ, Sakamoto HS, Garcia-Segura LM. The cellular effects of estrogens on neuroendocrine tissue. J Steroid Biochem 1988;30:195-207
8. Naftolin F. Brain aromatization of androgens. J Reprod Med 1994;39:257-61
9. Roberts V, Meunier H, Vaughan J, Rivier J, Rivier C, Vale W, et al. Production and regulation of inhibin subunits in pituitary gonadotropes. Endocrinology 1989;124:552-4
10. Mason AJ, Berkemeier LM, Schmelzer CH, Schwall RH. Activin B: Precursor sequences, genomic structure and in vitro activities. Mol Endocrinol 1989;3:1352-8
11. Weil SJ, Vendola K, Zhou J, Adesanya OO, Wang J, Okafor J, et al. Androgen receiptor gene expression in the primate ovary: Cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 1998;837:2479-85
12. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999;848:2951-6
13. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998;101:2622-9
14. Legro RS, Kunselman AR, Brzyski RG, Casson PR, Diamond MP, Schlaff WD, et al. NICHD Reproductive Medicine Network. The pregnancy in polycystic ovary syndrome II (PPCOS II) trial: Rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome. Contemp Clin Trials 2012;33:470-81
15. Dietrich JE. An update on adenomyosis in the adolescent. Curr Opin Obstet Gynecol 2010;22:388-92
16. Mousa NA, Bedaiwy MA, Casper RF. Aromatase inhibitors in the treatment of severe endometriosis. Obstet Gynecol 2007;109:1421-3
17. Nawathe A, Patwardhan S, Yates D, Harrison GR, Khan KS. Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG 2008;115:818-22
18. Parsanezhad ME, Azmoon M, Alborzi S, Rajaeefard A, Zarei A, Kazerooni T, et al. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril 2010;93:192-8
19. Sylvestre VT, Dunton CJ. Treatment of recurrent endometrial stromal sarcoma with letrozole: A case report and literature review. Horm Cancer 2010;1:112-5
20. Lee VC, Tang OS, Ng EH, Yeung WS, Ho PC. A pilot study on the use of letrozole with either misoprostol or mifepristone for termination of pregnancy up to 63 days. Contraception 2011;83:62-7
21. Misso ML, Wong JL, Teede HJ, Hart R, Rombauts L, Melder AM, et al. Aromatase inhibitors for PCOS: A systematic review and meta-analysis. Hum Reprod Update 2012;18:301-12
22. Abu Hashim H, Mashaly AM, Badawy A. Letrozole versus laparoscopic ovarian diathermy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: A randomized controlled trial. Arch Gynecol Obstet 2010;282:567-71
23. Abu Hashim H, Shokeir T, Badawy A. Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: A randomized controlled trial. Fertile Steril 2010;94:1405-9
24. Abdellah MS. Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome. Int J Gynaecol Obstet 2011;113:218-21
25. Badawy A, Mosbah A, Shady M. Anastrozole or letrozole for ovulatin induction in clomiphene-resistant women with polycystic ovarian syndrome: A prospective randomize trial. Fertil Steril 2008;89:1209-12
26. AI-Omari WR, Sulaiman WR, AI-Hadithi N. Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. Int J Gynaecol Obstet 2004;85:289-91
27. Kamath MS, Aleyamma TK, Chandy A, George K. Aromatase inhibitors in women with clomiphene citrate resistant: A randomized, double-blind, placebo-controlled trial. Fertil Steril 2010;94:2857-9
28. Abu Hashim H, EI Rakhawy M, Abd Elaal I. Randomized comparison of superovulation with letrozole vs. clomiphene citrate in an IUI program for women with recently surgically treated minimal to mild endometriosis. Acta Obstet Gynecol Scand 2012;91:338-45
29. Badawy A, Elnashar A, Totongy M. Clomiphene citrate or aromatase inhibitors combined with gonadotropins for superovulation in women undergoing intrauterine insemination: A prospective randomized trial. J Obstet Gynaecol 2010;30:617-21
30. Verpoest WM, kolibianakis E, Papanikolaou E, Smitz J, Van Steirteghem A, Devroey P. Aromatase inhibitors in ovarian stimulation for IVF/ICSI: A pilot study. Reprod Biomed Online 2006;13:166-72
31. Garcia-Velasco JA, Moreno L, Pacheco A, Guillen A, Duque L, Requena A, et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: A pilot study. Fertil Steril 2005;84:82-7
32. Ozmen B, Sonmezer M, Atabekoglu CS, Olmus H. Use of aromatase inhibitors in poor-responder patients reseiving GnRH antagonist protocols. Reprod Biomed Online 2009;19:478-85
33. Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, et al. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: A preliminary report. Hum Reprod 2004;19:2031-5
34. Mohsen IA, EI Din RE. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoin ICSI. Gynecol Endocrinol 2013;29:105-8
35. Fatemi HM, Popovic-Todorovic B, Donoso P, Papanikolaou E, Smitz J, Devroey P. Luteal phase oestradiol suppression by letrozole: A pilot study in oocyte donors. Reprod Biomed Online 2008;17:307-11
36. Garcia-Velasco JA, Quea G, Piro M, Mayoral M, Ruiz M, Toribio M, et al. Letrozole administration during the luteal phase after ovarian stimulatin impacts corpus luteum function: A randomized, placebo-controlled trial. Fertil Steril 2009;92:222-5
37. Maltaris T, Weigel M, Mueller A, Schmidt M, Seufert R, Fisch F, et al. Cancer and fertility preservation: Fertility preservation in breast cancer patients. Breast Cancer Res 2008;10:206
38. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, et al. Letrozole reduce estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006;91:3885-90
39. Azim AA, Costantini-Ferrando M, Lostritto K, Oktay K. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer parients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 2007;92:2197-200
40. Oktay K, Turkcuoglu I, Rodriguez-Wallberg KA. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod Biomed Online 2010;20:783-8
41. Azim AA, Costantini-ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: A prospective controlled study. J Clin Oncol 2008;26:2630-5
42. Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 2006;85:1761-5
43. Reefhuis J, Honein MA, Schieve LA, Rasmussen SA. National Birth Defects Prevention Study. Use of clomiphene citrate and birth defects, National Birth Defects prevention Study, 1997-2005. Hum Reprod 2011;26:451-7
44. Davies MJ, Moore VM, Willson KJ, Van Essen P, Priest K, Scott H, et al. Reproductive technologies and the risk of birth defects. N Engl J Med 2012;366:1803-13
45. Diamond MP, Mitwally M, Casper R, Ager J, Legro RS, Brzyski R, et al. NICHD Cooperative Reproductive Medicine Network. Estimating rates of multiple gestation pregnancies; sample size calculation from the assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial. Contemp Clin Trials 2011;32:902-8